Illumina Inc

Insider selling at Illumina signals caution: executives trim stakes amid mixed quarterly results and an upcoming NovaSeq X launch, urging investors to weigh valuation and product prospects.

Illumina insider selling signals routine portfolio rebalancing, not a market shift: insiders sold 1,259 shares at $116.51 on Feb 15, 2026—watch for future moves.